The global market for Transfusion Safety Diagnostics was valued at US$ 4262 million in the year 2024 and is projected to reach a revised size of US$ 6304 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Transfusion Safety Diagnostics Market

Transfusion Safety Diagnosticsrefer to the tests and tools used to ensure the safety and compatibility of blood before transfusion. These include detecting blood group antigens, antibodies, infectious agents, and crossmatching donor and recipient blood.

North American market for Transfusion Safety Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transfusion Safety Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Transfusion Safety Diagnostics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Transfusion Safety Diagnostics include Grifols S.A., Abbott, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Immucor, Inc., F. Hoffman-La Roche Ltd., QUOTIENT LIMITED, BAG Healthcare GmBH, DiaSorin S.p.A., Hologic, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Transfusion Safety Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfusion Safety Diagnostics.

The Transfusion Safety Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transfusion Safety Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transfusion Safety Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Transfusion Safety Diagnostics Market Report

Report Metric	Details
Report Name	Transfusion Safety Diagnostics Market
Accounted market size in year	US$ 4262 million
Forecasted market size in 2031	US$ 6304 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Instruments Kits & Reagents
Segment by Application	Hospitals Blood Banks Diagnostic Laboratories Plasma Fractionation Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grifols S.A., Abbott, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Immucor, Inc., F. Hoffman-La Roche Ltd., QUOTIENT LIMITED, BAG Healthcare GmBH, DiaSorin S.p.A., Hologic, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transfusion Safety Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Transfusion Safety Diagnostics Market growing?

Ans: The Transfusion Safety Diagnostics Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Transfusion Safety Diagnostics Market size in 2031?

Ans: The Transfusion Safety Diagnostics Market size in 2031 will be US$ 6304 million.

Who are the main players in the Transfusion Safety Diagnostics Market report?

Ans: The main players in the Transfusion Safety Diagnostics Market are Grifols S.A., Abbott, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Immucor, Inc., F. Hoffman-La Roche Ltd., QUOTIENT LIMITED, BAG Healthcare GmBH, DiaSorin S.p.A., Hologic, Inc.

What are the Application segmentation covered in the Transfusion Safety Diagnostics Market report?

Ans: The Applications covered in the Transfusion Safety Diagnostics Market report are Hospitals, Blood Banks, Diagnostic Laboratories, Plasma Fractionation Companies, Others

What are the Type segmentation covered in the Transfusion Safety Diagnostics Market report?

Ans: The Types covered in the Transfusion Safety Diagnostics Market report are Instruments, Kits & Reagents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Transfusion Safety Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instruments

1.2.3 Kits & Reagents

1.3 Market by Application

1.3.1 Global Transfusion Safety Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Blood Banks

1.3.4 Diagnostic Laboratories

1.3.5 Plasma Fractionation Companies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Transfusion Safety Diagnostics Market Perspective (2020-2031)

2.2 Global Transfusion Safety Diagnostics Growth Trends by Region

2.2.1 Global Transfusion Safety Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Transfusion Safety Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Transfusion Safety Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Transfusion Safety Diagnostics Market Dynamics

2.3.1 Transfusion Safety Diagnostics Industry Trends

2.3.2 Transfusion Safety Diagnostics Market Drivers

2.3.3 Transfusion Safety Diagnostics Market Challenges

2.3.4 Transfusion Safety Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Transfusion Safety Diagnostics Players by Revenue

3.1.1 Global Top Transfusion Safety Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Transfusion Safety Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Top Transfusion Safety Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Transfusion Safety Diagnostics Revenue

3.4 Global Transfusion Safety Diagnostics Market Concentration Ratio

3.4.1 Global Transfusion Safety Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Transfusion Safety Diagnostics Revenue in 2024

3.5 Global Key Players of Transfusion Safety Diagnostics Head office and Area Served

3.6 Global Key Players of Transfusion Safety Diagnostics, Product and Application

3.7 Global Key Players of Transfusion Safety Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Transfusion Safety Diagnostics Breakdown Data by Type

4.1 Global Transfusion Safety Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Transfusion Safety Diagnostics Forecasted Market Size by Type (2026-2031)

5 Transfusion Safety Diagnostics Breakdown Data by Application

5.1 Global Transfusion Safety Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Transfusion Safety Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Transfusion Safety Diagnostics Market Size (2020-2031)

6.2 North America Transfusion Safety Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Transfusion Safety Diagnostics Market Size by Country (2020-2025)

6.4 North America Transfusion Safety Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Transfusion Safety Diagnostics Market Size (2020-2031)

7.2 Europe Transfusion Safety Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Transfusion Safety Diagnostics Market Size by Country (2020-2025)

7.4 Europe Transfusion Safety Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Transfusion Safety Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Transfusion Safety Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Transfusion Safety Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Transfusion Safety Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Transfusion Safety Diagnostics Market Size (2020-2031)

9.2 Latin America Transfusion Safety Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Transfusion Safety Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Transfusion Safety Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Transfusion Safety Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Transfusion Safety Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Transfusion Safety Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Transfusion Safety Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Grifols S.A.

11.1.1 Grifols S.A. Company Details

11.1.2 Grifols S.A. Business Overview

11.1.3 Grifols S.A. Transfusion Safety Diagnostics Introduction

11.1.4 Grifols S.A. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.1.5 Grifols S.A. Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Transfusion Safety Diagnostics Introduction

11.2.4 Abbott Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 Ortho Clinical Diagnostics

11.3.1 Ortho Clinical Diagnostics Company Details

11.3.2 Ortho Clinical Diagnostics Business Overview

11.3.3 Ortho Clinical Diagnostics Transfusion Safety Diagnostics Introduction

11.3.4 Ortho Clinical Diagnostics Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.3.5 Ortho Clinical Diagnostics Recent Development

11.4 Bio-Rad Laboratories, Inc.

11.4.1 Bio-Rad Laboratories, Inc. Company Details

11.4.2 Bio-Rad Laboratories, Inc. Business Overview

11.4.3 Bio-Rad Laboratories, Inc. Transfusion Safety Diagnostics Introduction

11.4.4 Bio-Rad Laboratories, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.4.5 Bio-Rad Laboratories, Inc. Recent Development

11.5 Immucor, Inc.

11.5.1 Immucor, Inc. Company Details

11.5.2 Immucor, Inc. Business Overview

11.5.3 Immucor, Inc. Transfusion Safety Diagnostics Introduction

11.5.4 Immucor, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.5.5 Immucor, Inc. Recent Development

11.6 F. Hoffman-La Roche Ltd.

11.6.1 F. Hoffman-La Roche Ltd. Company Details

11.6.2 F. Hoffman-La Roche Ltd. Business Overview

11.6.3 F. Hoffman-La Roche Ltd. Transfusion Safety Diagnostics Introduction

11.6.4 F. Hoffman-La Roche Ltd. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.6.5 F. Hoffman-La Roche Ltd. Recent Development

11.7 QUOTIENT LIMITED

11.7.1 QUOTIENT LIMITED Company Details

11.7.2 QUOTIENT LIMITED Business Overview

11.7.3 QUOTIENT LIMITED Transfusion Safety Diagnostics Introduction

11.7.4 QUOTIENT LIMITED Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.7.5 QUOTIENT LIMITED Recent Development

11.8 BAG Healthcare GmBH

11.8.1 BAG Healthcare GmBH Company Details

11.8.2 BAG Healthcare GmBH Business Overview

11.8.3 BAG Healthcare GmBH Transfusion Safety Diagnostics Introduction

11.8.4 BAG Healthcare GmBH Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.8.5 BAG Healthcare GmBH Recent Development

11.9 DiaSorin S.p.A.

11.9.1 DiaSorin S.p.A. Company Details

11.9.2 DiaSorin S.p.A. Business Overview

11.9.3 DiaSorin S.p.A. Transfusion Safety Diagnostics Introduction

11.9.4 DiaSorin S.p.A. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.9.5 DiaSorin S.p.A. Recent Development

11.10 Hologic, Inc.

11.10.1 Hologic, Inc. Company Details

11.10.2 Hologic, Inc. Business Overview

11.10.3 Hologic, Inc. Transfusion Safety Diagnostics Introduction

11.10.4 Hologic, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025)

11.10.5 Hologic, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Grifols S A

Abbott

Ortho Clinical Diagnostics

Bio-Rad Laboratories Inc

Immucor

F. Hoffman-La Roche Ltd.

List of Tables

Table 1. Global Transfusion Safety Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instruments

Table 3. Key Players of Kits & Reagents

Table 4. Global Transfusion Safety Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Transfusion Safety Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Transfusion Safety Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Transfusion Safety Diagnostics Market Share by Region (2020-2025)

Table 8. Global Transfusion Safety Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Transfusion Safety Diagnostics Market Share by Region (2026-2031)

Table 10. Transfusion Safety Diagnostics Market Trends

Table 11. Transfusion Safety Diagnostics Market Drivers

Table 12. Transfusion Safety Diagnostics Market Challenges

Table 13. Transfusion Safety Diagnostics Market Restraints

Table 14. Global Transfusion Safety Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Transfusion Safety Diagnostics Market Share by Players (2020-2025)

Table 16. Global Top Transfusion Safety Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion Safety Diagnostics as of 2024)

Table 17. Ranking of Global Top Transfusion Safety Diagnostics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Transfusion Safety Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Transfusion Safety Diagnostics, Headquarters and Area Served

Table 20. Global Key Players of Transfusion Safety Diagnostics, Product and Application

Table 21. Global Key Players of Transfusion Safety Diagnostics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Transfusion Safety Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Transfusion Safety Diagnostics Revenue Market Share by Type (2020-2025)

Table 25. Global Transfusion Safety Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Transfusion Safety Diagnostics Revenue Market Share by Type (2026-2031)

Table 27. Global Transfusion Safety Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Transfusion Safety Diagnostics Revenue Market Share by Application (2020-2025)

Table 29. Global Transfusion Safety Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Transfusion Safety Diagnostics Revenue Market Share by Application (2026-2031)

Table 31. North America Transfusion Safety Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Transfusion Safety Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Transfusion Safety Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Transfusion Safety Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Transfusion Safety Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Transfusion Safety Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Transfusion Safety Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Transfusion Safety Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Transfusion Safety Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Transfusion Safety Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Transfusion Safety Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Transfusion Safety Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Transfusion Safety Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Transfusion Safety Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Transfusion Safety Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Grifols S.A. Company Details

Table 47. Grifols S.A. Business Overview

Table 48. Grifols S.A. Transfusion Safety Diagnostics Product

Table 49. Grifols S.A. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 50. Grifols S.A. Recent Development

Table 51. Abbott Company Details

Table 52. Abbott Business Overview

Table 53. Abbott Transfusion Safety Diagnostics Product

Table 54. Abbott Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 55. Abbott Recent Development

Table 56. Ortho Clinical Diagnostics Company Details

Table 57. Ortho Clinical Diagnostics Business Overview

Table 58. Ortho Clinical Diagnostics Transfusion Safety Diagnostics Product

Table 59. Ortho Clinical Diagnostics Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 60. Ortho Clinical Diagnostics Recent Development

Table 61. Bio-Rad Laboratories, Inc. Company Details

Table 62. Bio-Rad Laboratories, Inc. Business Overview

Table 63. Bio-Rad Laboratories, Inc. Transfusion Safety Diagnostics Product

Table 64. Bio-Rad Laboratories, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 65. Bio-Rad Laboratories, Inc. Recent Development

Table 66. Immucor, Inc. Company Details

Table 67. Immucor, Inc. Business Overview

Table 68. Immucor, Inc. Transfusion Safety Diagnostics Product

Table 69. Immucor, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 70. Immucor, Inc. Recent Development

Table 71. F. Hoffman-La Roche Ltd. Company Details

Table 72. F. Hoffman-La Roche Ltd. Business Overview

Table 73. F. Hoffman-La Roche Ltd. Transfusion Safety Diagnostics Product

Table 74. F. Hoffman-La Roche Ltd. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 75. F. Hoffman-La Roche Ltd. Recent Development

Table 76. QUOTIENT LIMITED Company Details

Table 77. QUOTIENT LIMITED Business Overview

Table 78. QUOTIENT LIMITED Transfusion Safety Diagnostics Product

Table 79. QUOTIENT LIMITED Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 80. QUOTIENT LIMITED Recent Development

Table 81. BAG Healthcare GmBH Company Details

Table 82. BAG Healthcare GmBH Business Overview

Table 83. BAG Healthcare GmBH Transfusion Safety Diagnostics Product

Table 84. BAG Healthcare GmBH Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 85. BAG Healthcare GmBH Recent Development

Table 86. DiaSorin S.p.A. Company Details

Table 87. DiaSorin S.p.A. Business Overview

Table 88. DiaSorin S.p.A. Transfusion Safety Diagnostics Product

Table 89. DiaSorin S.p.A. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 90. DiaSorin S.p.A. Recent Development

Table 91. Hologic, Inc. Company Details

Table 92. Hologic, Inc. Business Overview

Table 93. Hologic, Inc. Transfusion Safety Diagnostics Product

Table 94. Hologic, Inc. Revenue in Transfusion Safety Diagnostics Business (2020-2025) & (US$ Million)

Table 95. Hologic, Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Transfusion Safety Diagnostics Picture

Figure 2. Global Transfusion Safety Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Transfusion Safety Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Instruments Features

Figure 5. Kits & Reagents Features

Figure 6. Global Transfusion Safety Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Transfusion Safety Diagnostics Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Blood Banks Case Studies

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Plasma Fractionation Companies Case Studies

Figure 12. Others Case Studies

Figure 13. Transfusion Safety Diagnostics Report Years Considered

Figure 14. Global Transfusion Safety Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Transfusion Safety Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Transfusion Safety Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Transfusion Safety Diagnostics Market Share by Players in 2024

Figure 18. Global Transfusion Safety Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Transfusion Safety Diagnostics Revenue in 2024

Figure 20. North America Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Transfusion Safety Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Transfusion Safety Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Transfusion Safety Diagnostics Market Share by Region (2020-2031)

Figure 34. China Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Transfusion Safety Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Transfusion Safety Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Transfusion Safety Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Grifols S.A. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 50. Abbott Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 51. Ortho Clinical Diagnostics Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 53. Immucor, Inc. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 54. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 55. QUOTIENT LIMITED Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 56. BAG Healthcare GmBH Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 57. DiaSorin S.p.A. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 58. Hologic, Inc. Revenue Growth Rate in Transfusion Safety Diagnostics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37D12504

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Autonomous Ultrasound Guidance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9D20268

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Radiation Therapy Contouring Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Q19843

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Biliary and Pancreatic Drainage Stent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27T19786

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions